CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

HEALTHCARE SUPPLIER NEWS

Gilead backs $60M Hookipa round to fund immunotherapy R&D

Published: Mon, 11 Dec 2017 11:47:59 +0000
Gilead has joined Boehringer Ingelheim and Takeda on the list of investors in Hookipa Biotech. The Big Biotech participated in a $60 million (€50 million) series C intended to equip Hookipa to advance its cytomegalovirus vaccine and cancer candidate through early clinical testing.

'Epigenetic CRISPR' edits DNA without cutting it

Published: Fri, 08 Dec 2017 20:52:28 +0000
A Salk Institute team created a form of CRISPR/Cas9 that activates specific genes without making breaks in the DNA, which can cut down on harmful side effects.

Roche uncovers clues to improving checkpoint inhibition in cancer

Published: Fri, 08 Dec 2017 17:06:36 +0000
Checkpoint inhibitors to treat cancers, such as Roche’s Tecentriq, fail to work in as many as 80% of patients—a problem that their manufacturers have been trying to solve. Now Roche is uncovering data from a Tecentriq trial in bladder cancer patients that could provide clues to countering resistance.
Displaying results 10-12 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top